Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder

被引：0
|
作者：
Kennedy, S. [1 ]
Grouin, J. [2 ]
Cadour, S. [3 ]
Robert, V. [3 ]
Picarel-Blanchot, F. [4 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
[2] Univ Rouen, INSERM, U1219, Populat Hlth, Rouen, France
[3] IRIS, Biostat Dept, Suresnes, France
[4] IRIS, Neuropsychiat Innovat Therapeut Pole, Suresnes, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
METAANALYSIS;
D O I：
10.1016/S0924-977X(16)31450-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.007
引用
收藏
页码：S457 / S458
页数：2
相关论文
共 50 条
  • [1] Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder
    Kennedy, Sidney H.
    Grouin, Jean-Marie
    Cadour, Stephanie
    Robert, Veronique
    Picarel-Blanchot, Francoise
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2018, 33 (01)
  • [2] Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
    McIntyre, Roger S.
    Loft, Henrik
    Christensen, Michael Cronquist
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 575 - 585
  • [3] Efficacy of agomelatine for anxiety symptoms in adult patients with major depressive disorder
    Stein, D.
    Chimits, D.
    Picarel-Blanchot, F.
    Khoo, J. P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S59 - S60
  • [4] Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response
    Papakostas, George, I
    Nielsen, Rebecca Z.
    Dragheim, Marianne
    Tonnoir, Brigitte
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 101 : 72 - 79
  • [5] Efficacy of agomelatine versus venlafaxine on subjective sleep of patients with major depressive disorder
    Guilleminault, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S419 - S420
  • [6] The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
    Cao, Bing
    Park, Caroline
    Subramaniapillai, Mehala
    Lee, Yena
    Lacobucci, Michelle
    Mansur, Rodrigo B.
    Zuckerman, Hannah
    Phan, Lee
    McIntyre, Roger S.
    [J]. FRONTIERS IN PSYCHIATRY, 2019, 10
  • [7] EFFICACY OF AGOMELATINE IN ELDERLY PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Flynn, Patrick
    Heun, Reinhaud
    Corral, Ricardo
    Ahokas, Antti
    Nicolini, Humberto
    Teixeria, Joao
    Dehelean, Pompilia
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (S1): : 46 - 47
  • [8] Efficacy of vortioxetine versus other antidepressants on cognitive dysfunction in patients with major depressive disorder
    Baune, B. T.
    Brignone, M.
    Larsen, K. G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S470 - S470
  • [9] Maintenance of vortioxetine efficacy with long-term treatment of patients with major depressive disorder
    Vieta, E.
    Loft, H.
    Florea, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S458 - S459
  • [10] Sustained efficacy and safety of agomelatine versus placebo over 24 weeks in elderly out-patients suffering from major depressive disorder
    Heun, R.
    Corral, R.
    Ahokas, A.
    Nicolini, H.
    Teixeira, J. M.
    Dehelean, P.
    Picarel-Blanchot, F.
    De Bodinat, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S403 - S404
12345